CHAPS - The Men’s Health Charity www.tackleprostate.org PROSTATE CANCER To Screen or Not To Screen - That is the Only Question Chris Booth MBBS, FRCS Emeritus.

Slides:



Advertisements
Similar presentations
Using the duties as a lever for change Jill Evans Aneurin Bevan Health Board.
Advertisements

Cancer Research UK strategy and funding Simon Vincent.
Tuberculosis (TB): clinical diagnosis and management of tuberculosis and measures for its prevention and control March 2006.
Implementing NICE guidance
Health literacy Impact and action at a national level 26 July, 2014 Nicola Dunbar Director, Strategy and Development.
HEALTHY PEOPLE. Aims  Interpret evidence about a screening programme and decide whether it is worthwhile – for individuals or groups  Demonstrate an.
Management of a gonorrhoea ‘outbreak’ among university students Gill Bell Nurse Consultant Sexual Health Adviser Sheffield.
Chap 8: Adolescents, Young Adults, and Adults Instructor’s Name Semester, 200_.
Prostate Cancer One of the commonest causes of death in the Western World USA 2005 – 232,090 new cases – 30,350 deaths Lifetime risk of disease 16.6% Lifetime.
EVIDENCE AND DEBATE SCREENING FOR PROSTATE CANCER.
Prostates & Pissing in the Wind. The Laytons Bob December 25, 1925 – May 9, 2002 Jack July 18, 1950 – August 22, 2011.
Prostate Cancer Screening 2012 Paul L. Crispen, MD Department of Surgery University of Kentucky.
M Ravanbod Medical oncologist Bushehr – 11/91 A 50 y/o white man comes for check up and wants to discuss about prostate cancer. Negative family history.
Assessment of Colon & Prostate Cancer Screening in WA Peggy Hannon, PhD, MPH Alliance for Reducing Cancer NW.
How to Overcome Barriers and Develop Collaborative Guidelines Amir Qaseem, MD, PhD, MHA, FACP Chair, Guidelines International Network Director, Clinical.
Prostate Cancer Screening. Google Search “Prostate Cancer” “Google Health” prostate cancer (OK) “Should All Men Be Screened for Prostate Cancer?” ABC.
A/Prof Brian Cox Cancer Epidemiologist Dunedin. Research Associate Professor Brian Cox Hugh Adam Cancer Epidemiology Unit Department of Preventive and.
ESMO Patient Coalition Forum Prostate Cancer: Bridging the GAP in Europe Europa Uomo: Coalition of independent patient led prostate cancer groups. Louis.
Routine PSA: Evaluating the Evidence Sheldon Greenfield, MD Health Policy Research Institute University of California, Irvine October 23, 2012.
Commissioner Feedback for SLAM CQC Inspection in September 2015 Engagement with Member Practices 1.
Overdetection of prostate cancer ESMO Brussel 2007 Chris H.Bangma Erasmus University Medical Centre Rotterdam, The Netherlands.
PCa Screening New Areas of Research Francesco Montorsi Milan.
Prostate Cancer Coalition of NC A statewide collaborative effort by concerned organizations and individuals to support awareness, early detection, and.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
PROCABIO A European initiative to develop tailored treatment of prostate cancer by biomarkers.
Il PSA nello screening del carcinoma della prostata PRO Franco Gaboardi Urologia Ospedale San Raffaele Turro Milano.
Prostate Cancer Screening Guidelines Across Canada Environmental Scan July 2015.
Standard 10: Preventing Falls and Harm from Falls Accrediting Agencies Surveyor Workshop, 13 August 2012.
Decoding the USPSTF By: Dr Vikram Arora Heritage Valley Health System.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Prostate cancer update Suresh GANTA Consultant urological surgeon Manor Hospital.
Adult Social Care and Health Select Committee Cancer in Nottingham Julie O’Boyle Specialty Registrar Public Health NHS Nottingham City Dr Chris Packham.
Methods Three questionnaires were designed with reference to national guidelines and the PCRMP’s recommendations. These questionnaires were sent to PCTs,
Excess winter deaths and morbidity and the health risks associated with cold homes Chris Connell Implementation Consultant September 2015.
Date of download: 7/6/2016 From: Comparative Effectiveness of Alternative Prostate-Specific Antigen–Based Prostate Cancer Screening Strategies: Model Estimates.
PSA Consensus and The Prostate Cancer Risk Management Programme Karen Stalbow, Prostate Cancer UK Dr Ali Cooper, Prostate Cancer UK Annual Conference 2016.
Screening men for AAA Abdominal Aortic Aneurysm
1 “ Trouble Down Below ” Tuesday 21 st June 2016 The Royal National Hotel, Russell Square, London Generously supported by Prostate Cancer UK Annual Conference.
How Do We Individualize Guidelines in an Era of Personalized Medicine? Douglas K. Owens, MD, MS VA Palo Alto Health Care System Stanford University, Stanford.
Risk-adapted prostate cancer (PCa) early detection study based on a “baseline” PSA value in young men – a prospective multicenter randomized trial (PROBASE)
Jane E Scullion Respiratory Nurse Consultant
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Definition of Cancer Screening
2017 USPSTF Draft Recommendations for Prostate Cancer Screening
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Surveillance. Public Health Approach Surveillance What is the Problem ? Problem Risk Factor Identification : What Is the Cause ? Intervention Evaluation.
Dr. John Jordan Dr. Stephen Pautler
Dr James Carlton, Medical Adviser
PSA testing.
Volume 61, Issue 3, Pages (March 2012)
Volume 63, Issue 4, Pages (April 2013)
Prostate Cancer Screening- Update
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Active Surveillance for Low Risk Prostate Cancer
Commissioner Feedback for SLAM CQC Inspection in September 2015
National Cancer Center
Prostate Cancer Update
Volume 54, Issue 3, Pages (September 2008)
NCD situation in the Palestine
PSA (Prostate Specific Antigen) - what’s new
Does PSA Testing Influence the Natural History of Prostate Cancer?
Empowering Members to Know Your Health & Own Your Health.
NHS LONG TERM PLAN.
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5th June 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On.
Standardised follow-up
Meeting with EG PHC Ev. underrubrik Förnamn Efternamn.
Prostate cancer screening beyond PSA – STHLM3 and/or MRI
Assessing a Patient’s Individual Risk of Biopsy-detectable Prostate Cancer: Be Aware of Case Mix Heterogeneity and A Priori Likelihood  Jan F.M. Verbeek,
Presentation transcript:

CHAPS - The Men’s Health Charity PROSTATE CANCER To Screen or Not To Screen - That is the Only Question Chris Booth MBBS, FRCS Emeritus Consultant Urologist Clinical Advisory Board, Tackle Clinical Director, CHAPS Charity 1

CHAPS - The Men’s Health Charity 2

CHAPS - The Men’s Health Charity 3

SIGNIFICANT PUBLICATIONS CHAPS - The Men’s Health Charity 2008: BJU Int, 101, Tyrol Prostate Cancer Demonstration Project: 25% benefit 2009, ‘12, ‘14: NEJM, NEJM, Lancet ERSPC 2014: BJU Int, 114, Guideline of Guidelines 21% benefit 4

2015: European Urol, 68(3), Organised PSA Screening V. Opportunistic Testing CHAPS - The Men’s Health Charity Av. age 66, PSA /1396(1022)/†79 NNI 139 at 18y NND 13 V. Av. age 68, PSA 8.7 V. 9949/962(361)/†122 (risk reduction 42%) V. NNI 493 at 18y V. NND PCRMP: Public Health England Benefits and Risks of PSA Testing Prostate Cancer UK Consensus Statements on PSA Testing in Asymptomatic Men in the UK 5

2016 EUROPA UOMO SCREENING STRATEGY A Strategy for Prostate Cancer Screening In Europe Monique J Roobol CHAPS - The Men’s Health Charity What Can Be Achieved By Screening? What is Happening in Daily Practice? -Guidelines: compliance V. non-compliance -Controlled V. uncontrolled screening -Informed decision/biopsies/imaging/MDTs/new treatments/active surveillance What is the Way to Go? -US Preventive Services Task Force: NO!! -Controlled screening (± risk assessment?) -Implementation - HOW?? 6

US Preventive Services Task Force, 2012 Recommended against screening for all ages CHAPS - The Men’s Health Charity No urologists No identification of risk (FH, race) Metastatic presentation rising Are we going to go back to the 1980s!? 7

Towards Controlled Screening CHAPS - The Men’s Health Charity Raise awareness of PCa Raise awareness of risk Educate commissioners and providers Introduce baseline testing Introduce risk profiling Ensure imaging before biopsy Standardise best practice 8

Implementation Prostatic Assessment Clinic SymptomsScreening No problem No action Urologist Nurse Specialist Drugs Continue ReviewNo Improvement 2/52 Target USN GPSI Urologist Complaint Duration Past History Medication Abdominal examination Rectal examination PSA Watch/Wait Discharge Primary Care Prostate Clinic CHAPS - The Men’s Health Charity 9

CHAPS - The Men’s Health Charity 10

CHAPS - The Men’s Health Charity 11